Arterial Stents Market

The global market value of arterial stents was valued at USD 13.6 billion in 2023 and is projected to grow at a CAGR of 9.8% during the forecast period. An increasing number of cardiac patients in all over the world due to lifestyle imbalance and rising demand for minimally invasive procedures is driving growth in the market. Technological advancements in stent designs and materials are fueling the market growth significantly.

Increasing demand for PCI procedures, and a rapidly growing aging population is driving demand in the market. An increasing number of patients suffering from coronary artery diseases, and peripheral artery diseases is driving growth in the market.

Growth Drivers

The arterial stents market is growing due to increasing healthcare expenditures, and the rising number of patients of coronary arteries due to lack of physical activity. Emerging economies with an increasing elderly population and rising healthcare expenditure is expected to offer growth opportunities. Increasing research and development activities in the region is significantly contributing to market growth.

The market witnessed growth due to several companies investing in developing new products. The focus on launching innovative products and obtaining regulatory approvals is expected to improve the availability of advanced options, encourage wider usage of stents, and further boost the market's growth. Increasing demand for metallic collapse in the market is significantly fueling the growth in the market.

An increasing number of patients suffering from hypertension, diabetes, and stress is driving the market towards significant growth. Cardiac patients worldwide are increasing rapidly due to obesity, stress, diabetes, and lifestyle imbalance. Increasing awareness among the people about stent replacement is driving growth in the market significantly. Rising number of cardiac patients worldwide are the key reason behind the growth in the market.

Segmentation

Arterial Stents Market by Product Segmentation

·         Vascular

o   Coronary Stents

o   Peripheral Stents

§  Iliac Artery Stents

§  Femoral Artery Stents

§  Carotid Artery Stents

§  Renal Artery Stents

§  Other Peripheral Stents

o   Neurovascular Stents

§  Intracranial Stents

§  Flow Diverters

·         Non-vascular Stents

o   Gastrointestinal Stents

§  Biliary

§  Duodenal

§  Colonic

§  Pancreatic

§  Esophageal Stents

o   Pulmonary (Airway) Stents

§  Silicone Airway

§  Metallic Airway

o   Urological Stents

o   Others

Arterial Stents Market by Material

·         Metallic Stents

·         Non-metallic Stents

Arterial Stents End User Segmentation

·         Hospitals

·         Ambulatory Care Centers (ACS)

·         Specialty Clinics

By Region

·         Asia Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Arterial Stents Market by Material Segmentation

Based on the materials, the arterial stents market is segmented into metallic, and non-metallic stents. Metallic stents are the leading segment in the market and are expected to dominate during the forecast period. Metallic stents are made of alloy (stainless steel) and is usually preferred for its exceptional mechanical strength, flexibility, and resilience under the physical stresses encountered during stent deployment.

Non-elastic stents do collapse easily, and thus not in use frequently. Non-metallic stents lack radiopacity, making placement more difficult. Permanent metallic stents provide lasting supports for patients at high risk of artery collapse. Degradation is possible in case of non-metallic stents, and these do collapse easily.

Arterial Stents Market by End-User Segmentation

On the basis of the end-user segmentation, the arterial stents market is segmented into Hospitals, Ambulatory Surgical centers, and Specialty Clinics. Hospitals are the leading segment because it handles large volume of patients especially those requiring vascular or interventional procedures. Majority of angioplasty and stenting procedures are drone inside the hospitals. The presence of specialized healthcare professionals makes the hospital segment an important one for the growth in the market. Acute heart attacks and stroke cases are easily manageable in hospitals due to the facilities available in them.

The facility of emergency, and critical care units is the reason behind the significant growth of the hospital segment in the market. Stent processes done in hospital settings are mostly covered by insurance. Hospitals employ interventional cardiologists and vascular surgeons who are skilled in stent implementation.

Ambulatory surgical centers are outpatient facilities, where minimally invasive procedures take place efficiently for the treatment of the patients. The stenting process inside ambulatory surgical centers is more cost-effective and having an edge over hospitals in some terms. ASCs meet strict regulatory and safety standards especially for high risk cardiovascular procedures.

Specialty Clinics are focused on targeted care and Cardiologists in these clinics provide targeted care. Cardiologists in these clinics prefer advanced stents driving the demand for premium products.

Regional Outlook

Based on the regions, the Arterial Stents Market is analyzed into 5 types: Asia Pacific, Europe, North America, Latin America, and Europe. Due to the rising prevalence of chronic diseases, North America is the leading region and is expected to dominate the market during the forecast period.

Developed healthcare infrastructure and rising awareness among the people about available technologies are driving growth in the market significantly. Due to the high prevalence of coronary artery disease, which drives demand for stent procedures.

Major companies like Abbott Laboratories and Medtronic Plc. are based in or heavily invested in North America, facilitating their investigation and product availability. With an increasing number of older adults, who are more susceptible to artery-related diseases, demand for arterial stents continues to rise. The Asia Pacific region is also witnessing growth during the forecast period. The increasing number of coronary artery patients in the region is driving demand in the market. Rising disposable income and increasing prevalence of cardiovascular diseases are fueling the market growth. India is expected to lead in the drug-eluting stent market growth.

Europe is experiencing growth in the market due to the high incidence of coronary artery diseases due to aging population, and unhealthy life-style. Innovations in stent design, such as drug-eluting stents (DES) and bioresorbable vascular scaffolds (BVS), improve patient outcomes by reducing restenosis rates and enhancing safety.

Key Players

·         Medtronic Plc

·         B. Braun

·         Shanghai Microport Medical Company Ltd.

·         Abbott Laboratories

·         Terumo Corporation

·         Biosensors International Group Ltd.

·         Transluminal

·         Boston Scientific Corporation

·         Elixir Medical Corporation

·         Sahajanand Medical Technologies Ltd.

·         Lepu Medical Technologies Beijing co. ltd.

·         Meril Lifesciences Pvt. Ltd.

·         Other Players